Bladder cancer research rife with new approaches
Wednesday, October 5, 2016 - 04:33
in Health & Medicine
The FDA approval of Tecentriq ushered in the first new treatment for advanced bladder cancer in 30 years.
The FDA approval of Tecentriq ushered in the first new treatment for advanced bladder cancer in 30 years.